Mediwell Life Science Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 17 Days
- Last Filing with ROC 31 Mar 2018
- Revenue Growth -18.42%
- Profit Growth 9.85%
- Ebitda -7.75%
- Net Worth -63.60%
- Total Assets -13.26%
About Mediwell Life Science
Mediwell Life Science Private Limited (MLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 January 2014 and has a history of 11 years. Its registered office is in Sangli, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ganesh Kumbhar, Gangadhar Ambole, Prashant Ambole, and Two other members serve as directors at the Company.
Company Details
- Location
Sangli, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24233PN2014PTC150163
- Company No.
150163
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jan 2014
- Date of AGM
29 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Mediwell Life Science?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ganesh Kumbhar  | Director | 10-Sep-2015 | Current |
| Gangadhar Ambole | Director | 10-Sep-2015 | Current |
| Prashant Ambole | Director | 10-Sep-2015 | Current |
| Pradip Ambole | Director | 13-Jan-2014 | Current |
| Pravinkumar Jha | Director | 13-Jan-2014 | Current |
Financial Performance of Mediwell Life Science.
Mediwell Life Science Private Limited, for the financial year ended 2018, experienced significant reduction in revenue, with a 18.42% decrease. The company also saw a slight improvement in profitability, with a 9.85% increase in profit. The company's net worth observed a substantial decline by a decrease of 63.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mediwell Life Science?
In 2018, Mediwell Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mediwell Life Science?
Unlock and access historical data on people associated with Mediwell Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mediwell Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mediwell Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.